Figure 2.

Differences in adjusted restricted median survival time to all-cause mortality over a period of 36 months. The model was adjusted for of age, sex, educational attainment, insurance plan, types of anticoagulant, CHA₂DS₂VAS_c, and HASBLED scores. CAD, coronary artery disease; CHA₂DS₂-VAS_c, congestive heart failure, hypertension, age≥75 years, diabetes mellitus, stroke or transient ischaemic attack (TIA), vascular disease, age 65–74 years, sex category; CHF, congestive heart failure; CSMBS, civil servant medical benefit scheme; DOAC, direct oral anticoagulant; HASBLED, hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile INR, elderly (>65 years), drugs/alcohol concomitantly; NGS, non-government-based scheme; SSS, social-security scheme; UCS, universal coverage scheme; VKA, vitamin K antagonist.